UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels

PloS one, 2014-09, Vol.9 (9), p.e107468-e107468

2014

Volltextzugriff (PDF)

Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action

Nature communications, 2020-11, Vol.11 (1), p.5848-13, Article 5848

2020

Volltextzugriff (PDF)

Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas

PloS one, 2016-12, Vol.11 (12), p.e0168284-e0168284

2016

Volltextzugriff (PDF)

Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity

Genome Biology, 2018-09, Vol.19 (1), p.130-14, Article 130

2018

Volltextzugriff (PDF)

Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes

Nature communications, 2023-01, Vol.14 (1), p.175-175, Article 175

2023

Volltextzugriff (PDF)

A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications

Frontiers in pharmacology, 2023-05, Vol.14, p.1096366-1096366

2023

Volltextzugriff (PDF)

Genetic Architecture of MicroRNA Expression: Implications for the Transcriptome and Complex Traits

American journal of human genetics, 2012-06, Vol.90 (6), p.1046-1063

2012

Volltextzugriff (PDF)

Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia

Molecular diagnosis & therapy, 2017-12, Vol.21 (6), p.621-631

2017

Volltextzugriff (PDF)

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

Genomics, proteomics & bioinformatics, 2017-04, Vol.15 (2), p.82-93

2017

Volltextzugriff (PDF)

Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma

International journal of molecular sciences, 2021-10, Vol.22 (20), p.11168

2021

Volltextzugriff (PDF)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

Genomics, proteomics & bioinformatics, 2014-10, Vol.12 (5), p.198-209

2014

Volltextzugriff (PDF)

The impact of the Cancer Genome Atlas on lung cancer

Translational research : the journal of laboratory and clinical medicine, 2015-12, Vol.166 (6), p.568-585

2015

Volltextzugriff (PDF)

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy

Pharmacogenomics, 2013-02, Vol.14 (3), p.315-324

2013

Volltextzugriff (PDF)

High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro

Molecular cancer therapeutics, 2016-05, Vol.15 (5), p.1123-1131

2016

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

Revealing Pan-Histology Immunomodulatory Targets in Pediatric Central Nervous System Tumors

Cancers, 2023-11, Vol.15 (22), p.5455

2023

Volltextzugriff (PDF)

Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer： EGFR and beyond

Ai zheng, 2015-04, Vol.34 (4), p.149-160, Article 7

2015

Volltextzugriff (PDF)

Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

American journal of human genetics, 2007-09, Vol.81 (3), p.427-437

2007

Volltextzugriff (PDF)

Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling

Cancers, 2021-02, Vol.13 (4), p.885

2021

Volltextzugriff (PDF)

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis

Pharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.569

2024

Volltextzugriff (PDF)

A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer

Frontiers in oncology, 2021-05, Vol.11, p.675215-675215

2021

Volltextzugriff (PDF)

Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma

Cancers, 2024-05, Vol.16 (9), p.1723

2024

Volltextzugriff (PDF)

A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect

Thrombosis research, 2012-10, Vol.130 (4), p.602-606

2012

Volltextzugriff (PDF)

The regulatory effect of miRNAs is a heritable genetic trait in humans

BMC genomics, 2012-08, Vol.13 (1), p.383-383, Article 383

2012

Volltextzugriff (PDF)

Pharmacogenomic discovery using cell-based models

Pharmacological reviews, 2009-12, Vol.61 (4), p.413-429

2009

Volltextzugriff (PDF)

1 – 25 von 608

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(573)
Mit Volltextzugriff
(508)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(418)
Life Sciences & Biomedicine
(351)
Humans
(293)
Female
(146)
Male
(124)
Middle Aged
(80)
Oncology
(75)
Adult
(74)
Animals
(68)
Aged
(64)
Gene Expression
(54)
Science & Technology - Other Topics
(51)
Genetics & Heredity
(50)
Genomes
(50)
Multidisciplinary Sciences
(49)
Biological And Medical Sciences
(48)
Cancer
(45)
Mice
(41)
General & Internal Medicine
(40)
Genome-Wide Association Study
(39)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels

Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action

Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas

Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity

Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes

A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications

Genetic Architecture of MicroRNA Expression: Implications for the Transcriptome and Complex Traits

Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

The impact of the Cancer Genome Atlas on lung cancer

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy

High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Revealing Pan-Histology Immunomodulatory Targets in Pediatric Central Nervous System Tumors

Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer： EGFR and beyond

Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide Approach

Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis

A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer

Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma

A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect

The regulatory effect of miRNAs is a heritable genetic trait in humans

Pharmacogenomic discovery using cell-based models

Aktive Filter

Suchergebnisse filtern